NORTH AMERICAN CAN COM NPV (OTCMKTS:USMJ) is a deep sub-penny micro-cap stock in the marijuana space that has started to garner attention as the stock bounces up the chart. The company has recently announced a new website pursuant to the company’s recent partnership with Puration Inc, which may be part of stirring up interest.
The site is apparently “dedicated to the coming official launch of EVERx CBD Infused Bottled Water. EVERx is a new sports, fitness and wellness nutritional supplement brand specializing in products infused with cannabidiol (CBD). Puration licensed from USMJ the rights to develop and market a CBD infused water. EVERx CBD Infused Bottled Water is the first EVERx brand commercial launch. On Thursday, February 2nd, 2017 an official EVERx CBD Infused Bottled Water product launch event scheduled to take place at a major industry trade show in March will be announced.”
NORTH AMERICAN CAN COM NPV (OTCMKTS:USMJ) promulgates itself as a company that was founded on the core belief that “cannabis makes people’s lives better. Cannabis can fight disease, improve wellness and do so in an environmentally sustainable manner. North American Cannabis Holdings is dedicated to finding the best possible applications for cannabis to serve consumers.”
The company plans to maintain the AmeriCanna Cafe in-house, but otherwise spinoff future enterprise cannabis consumer product pilots ready for production in transactions similar to the recent Puration transaction.
Find out when $USMJ stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, USMJ has recently been acting in partnership with Puration Inc. The potential for gains on the top line as a consequence of that project may be fueling the stock.
The company also recently announced favorable sales performance since the beginning of 2017. According to the Jan 26 release, the data reinforces the Company’s previously announced anticipated fifty percent (50%) increase in first calendar quarter sales of the previous quarter. With approximately $500,000 in annual sales and averaging $125,000 in quarterly sales, the Company anticipates realizing an additional $60,000 in sales from January 1st through March 31st.
In addition, the Company recently entered into a new distribution agreement with a brand name drugstore to sell one of its pilot fitness, health and wellness supplements that is anticipated to add an additional $60,000 in sales in the first calendar quarter of 2017. Results in the first few weeks of the year have been in line with the anticipated additional sales.
That folds into a new dividend strategy recently introduced by the company. According to the company’s release, “Based on the personal experience of one of USMJ’s founder with a daughter that discovered relief from a seizure disorder through the use of CBD, USMJ entered the cannabis sector piloting various cannabis enterprises in the fall of 2013. The idea at first was to find one specific enterprise through the piloting process on which the Company could concentrate all its efforts. What USMJ management discovered instead, is that the cannabis sector at large was in need of a business that could continuously connect investors and cannabis enterprise entrepreneurs. The spinoff last year of a cannabis extraction enterprise into Puration, Inc. (USOTC: PURA) and the subsequent dividend of PURA stock to USMJ shareholders has been a milestone event in the construction of a sustainable operation that can continuously connect investors and cannabis entrepreneurs. Now the Company has executed a second spinoff transaction with Alternet Systems, Inc. (USOTC: ALYI) and more are in the works.”
Traders will note in excess of 430% during the past month in terms of shareholder gains in the name. This is emblematic of the stock. USMJ stock has evidenced sudden upward volatility on many prior occasions. What’s more, the listing has seen an influx in interest of late, with the stock’s recent average trading volume running above 320% above the average volume levels in play in this stock over the longer term.
Earning a current market cap value of $19.3M, USMJ has virtually no cash on the books, which is balanced by virtually no total current liabilities. USMJ is pulling in trailing 12-month revenues of $554K. In addition, the company is seeing major top line growth, with y/y quarterly revenues growing at 40.2%. We will update the story again soon as developments transpire. For continuing coverage on shares of $USMJ stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!